Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Assessing outcomes in a lupus nephritis cohort over a 40-year period

Title: Assessing outcomes in a lupus nephritis cohort over a 40-year period
Authors: Gisca, E; Duarte, L; Farinha, F; Isenberg, DA
Source: Rheumatology , 60 (4) pp. 1814-1822. (2021)
Publication Year: 2021
Collection: University College London: UCL Discovery
Subject Terms: 40-year period; autoantibodies; end-stage renal disease; ethnicity; long-term follow-up; lupus nephritis; mortality
Description: OBJECTIVES: To characterize a LN cohort over 40 years, assessing its evolution, analysing two major outcomes: the development of end-stage renal disease and mortality rates in the first 5 years after LN diagnosis. METHODS: An observational retrospective study of patients with LN, followed up from 1975 at University College Hospital. Patients were divided into four groups, depending on the decade of LN diagnosis: 1975-1985 (D1), 1986-1995 (D2), 1996-2005 (D3) and 2006-2015 (D4). Comparison between groups was performed with respect to demographic, clinical, serological and histological characteristics and outcome. RESULTS: Two hundred and nineteen patients with LN were studied. There was a change in ethnic distribution, with a decreasing proportion of Caucasians (58.6% in D1 to 31.3% in D4, P = 0.018) and increase in African-ancestry (17.2% in D1 to 39.6% in D4, P = 0.040). Serological and histological patterns changed throughout time, with a reduction in class IV nephritis (51.7% in D1 to 27.1% in D4, P = 0.035), and increase in class II nephritis (10% in D2 to 18.8% in D4, P = 0.01) and anti-extractable nuclear antigen antibody positivity (17.2% in D1 to 83.3% in D4, P = 0.0001). The 5-year mortality rates decreased from D1 (24.1%) to D2 (4%), stabilizing for the next 30 years. The 5-year progression to end-stage renal disease remained stable over the decades. CONCLUSION: Despite the changes in treatment of LN in the past 20 years, we have reached a plateau in 5-year mortality and progression to end-stage renal disease rates, suggesting that new therapeutic and management approaches, and strategies to enhance adherence, are needed to improve outcomes further in LN patients.
Document Type: article in journal/newspaper
File Description: text
Language: English
Relation: https://discovery.ucl.ac.uk/id/eprint/10114294/
Availability: https://discovery.ucl.ac.uk/id/eprint/10114294/3/Isenberg_Assessing%20outcomes%20in%20a%20lupus%20nephritis%20cohort%20over%20a%2040-year%20period_AAM.pdf; https://discovery.ucl.ac.uk/id/eprint/10114294/
Rights: open
Accession Number: edsbas.F2A871D7
Database: BASE